Association of hyperuricemia and pulmonary hypertension: A systematic review and meta-analysis

Objectives: To investigate the association of hyperuricemia with pulmonary hypertension (PH) in term of subsequent development, severity, and prognosis of PH. Methods: The authors systematically reviewed articles from databases and conducted meta-analyses as follows: (1) association of serum uric ac...

Full description

Saved in:
Bibliographic Details
Published inModern rheumatology Vol. 29; no. 6; pp. 1031 - 1041
Main Authors Uk Kang, Tae, Park, Kyu Yong, Kim, Hyun Jung, Ahn, Hyeong Sik, Yim, Shin-Young, Jun, Jae-Bum
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 02.11.2019
Subjects
Online AccessGet full text
ISSN1439-7595
1439-7609
1439-7609
DOI10.1080/14397595.2018.1537555

Cover

Abstract Objectives: To investigate the association of hyperuricemia with pulmonary hypertension (PH) in term of subsequent development, severity, and prognosis of PH. Methods: The authors systematically reviewed articles from databases and conducted meta-analyses as follows: (1) association of serum uric acid (UA) levels with the presence of PH; (2) association between serum UA levels and subsequent development of PH, in terms of odds ratio of the development of PH; and (3) association of serum UA levels with severity and prognosis of PH, in terms of pulmonary arterial pressure and hazard ratio of death. Results: Twenty-six studies published between 1999 and 2017 were included. The level of serum UA was higher in subjects with PH than subjects without PH and this finding was observed regardless of status of diuretics use or renal function. The odds ratio of the development of PH was 2.32 (95% CI, 1.05-5.15) in subjects with hyperuricemia. Pulmonary arterial pressure among subjects with PH was also higher in subjects with hyperuricemia than subjects with normouricemia. There was a 19% increased hazard ratio of death (95% CI, 1.06-1.33) among patients with PH who had hyperuricemia. Conclusion: Hyperuricemia is associated with the subsequent development, worse severity and poor prognosis of PH.
AbstractList To investigate the association of hyperuricemia with pulmonary hypertension (PH) in term of subsequent development, severity, and prognosis of PH. The authors systematically reviewed articles from databases and conducted meta-analyses as follows: (1) association of serum uric acid (UA) levels with the presence of PH; (2) association between serum UA levels and subsequent development of PH, in terms of odds ratio of the development of PH; and (3) association of serum UA levels with severity and prognosis of PH, in terms of pulmonary arterial pressure and hazard ratio of death. Twenty-six studies published between 1999 and 2017 were included. The level of serum UA was higher in subjects with PH than subjects without PH and this finding was observed regardless of status of diuretics use or renal function. The odds ratio of the development of PH was 2.32 (95% CI, 1.05-5.15) in subjects with hyperuricemia. Pulmonary arterial pressure among subjects with PH was also higher in subjects with hyperuricemia than subjects with normouricemia. There was a 19% increased hazard ratio of death (95% CI, 1.06-1.33) among patients with PH who had hyperuricemia. Hyperuricemia is associated with the subsequent development, worse severity and poor prognosis of PH.
Objectives: To investigate the association of hyperuricemia with pulmonary hypertension (PH) in term of subsequent development, severity, and prognosis of PH.Methods: The authors systematically reviewed articles from databases and conducted meta-analyses as follows: (1) association of serum uric acid (UA) levels with the presence of PH; (2) association between serum UA levels and subsequent development of PH, in terms of odds ratio of the development of PH; and (3) association of serum UA levels with severity and prognosis of PH, in terms of pulmonary arterial pressure and hazard ratio of death.Results: Twenty-six studies published between 1999 and 2017 were included. The level of serum UA was higher in subjects with PH than subjects without PH and this finding was observed regardless of status of diuretics use or renal function. The odds ratio of the development of PH was 2.32 (95% CI, 1.05-5.15) in subjects with hyperuricemia. Pulmonary arterial pressure among subjects with PH was also higher in subjects with hyperuricemia than subjects with normouricemia. There was a 19% increased hazard ratio of death (95% CI, 1.06-1.33) among patients with PH who had hyperuricemia.Conclusion: Hyperuricemia is associated with the subsequent development, worse severity and poor prognosis of PH.Objectives: To investigate the association of hyperuricemia with pulmonary hypertension (PH) in term of subsequent development, severity, and prognosis of PH.Methods: The authors systematically reviewed articles from databases and conducted meta-analyses as follows: (1) association of serum uric acid (UA) levels with the presence of PH; (2) association between serum UA levels and subsequent development of PH, in terms of odds ratio of the development of PH; and (3) association of serum UA levels with severity and prognosis of PH, in terms of pulmonary arterial pressure and hazard ratio of death.Results: Twenty-six studies published between 1999 and 2017 were included. The level of serum UA was higher in subjects with PH than subjects without PH and this finding was observed regardless of status of diuretics use or renal function. The odds ratio of the development of PH was 2.32 (95% CI, 1.05-5.15) in subjects with hyperuricemia. Pulmonary arterial pressure among subjects with PH was also higher in subjects with hyperuricemia than subjects with normouricemia. There was a 19% increased hazard ratio of death (95% CI, 1.06-1.33) among patients with PH who had hyperuricemia.Conclusion: Hyperuricemia is associated with the subsequent development, worse severity and poor prognosis of PH.
Objectives: To investigate the association of hyperuricemia with pulmonary hypertension (PH) in term of subsequent development, severity, and prognosis of PH. Methods: The authors systematically reviewed articles from databases and conducted meta-analyses as follows: (1) association of serum uric acid (UA) levels with the presence of PH; (2) association between serum UA levels and subsequent development of PH, in terms of odds ratio of the development of PH; and (3) association of serum UA levels with severity and prognosis of PH, in terms of pulmonary arterial pressure and hazard ratio of death. Results: Twenty-six studies published between 1999 and 2017 were included. The level of serum UA was higher in subjects with PH than subjects without PH and this finding was observed regardless of status of diuretics use or renal function. The odds ratio of the development of PH was 2.32 (95% CI, 1.05-5.15) in subjects with hyperuricemia. Pulmonary arterial pressure among subjects with PH was also higher in subjects with hyperuricemia than subjects with normouricemia. There was a 19% increased hazard ratio of death (95% CI, 1.06-1.33) among patients with PH who had hyperuricemia. Conclusion: Hyperuricemia is associated with the subsequent development, worse severity and poor prognosis of PH.
Author Uk Kang, Tae
Ahn, Hyeong Sik
Jun, Jae-Bum
Park, Kyu Yong
Yim, Shin-Young
Kim, Hyun Jung
Author_xml – sequence: 1
  givenname: Tae
  orcidid: 0000-0003-1467-2281
  surname: Uk Kang
  fullname: Uk Kang, Tae
  organization: Health Insurance Policy Research Institute, National Health Insurance Service
– sequence: 2
  givenname: Kyu Yong
  surname: Park
  fullname: Park, Kyu Yong
  organization: Department of Physical Medicine and Rehabilitation, Ajou University School of Medicine, Suwon
– sequence: 3
  givenname: Hyun Jung
  orcidid: 0000-0003-2018-2385
  surname: Kim
  fullname: Kim, Hyun Jung
  organization: Department of Preventive Medicine, College of Medicine, Korea University
– sequence: 4
  givenname: Hyeong Sik
  orcidid: 0000-0002-2084-7466
  surname: Ahn
  fullname: Ahn, Hyeong Sik
  organization: Department of Preventive Medicine, College of Medicine, Korea University
– sequence: 5
  givenname: Shin-Young
  orcidid: 0000-0002-8521-6331
  surname: Yim
  fullname: Yim, Shin-Young
  email: syyim@ajou.ac.kr
  organization: Department of Physical Medicine and Rehabilitation, Ajou University School of Medicine, Suwon
– sequence: 6
  givenname: Jae-Bum
  orcidid: 0000-0002-0208-0505
  surname: Jun
  fullname: Jun, Jae-Bum
  email: junjb@hanyang.ac.kr
  organization: Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30334638$$D View this record in MEDLINE/PubMed
BookMark eNqFkUFv2yAYhtHUam2z_YRNPvbiDIyxTXdpVHVbpUi9tNehL_ChMdmQAW7lf1-nSS49rCcQPM-L-N4LcuKDR0K-MLpktKPfWM1lK6RYVpR1SyZ4K4T4QM5352XbUHly3M_QGblI6S-lXMhOfiRnnHJeN7w7J79XKQXtILvgi2CLP9MW4xidxsFBAd4U27Efgoc47e8y-jSzV8WqSFPKOMyqLiI-OXx-5QfMUIKHfkoufSKnFvqEnw_rgjz-uH24-VWu73_e3azWpa5Fk8vKNMaAsbJuKKsqTqUQ1IIGoTctUkCUGyaEphxrVlHERjNTGVlZw7hpLV-Qy33uNoZ_I6asBpc09j14DGNS1ZwqOkFlPaNfD-i4GdCobXTD_Dt1nMkMfN8DOoaUIlqlXX4dUI7gesWo2jWgjg2oXQPq0MBsizf28YH3vOu957wNcYDnEHujMkx9iDaC1y4p_v-IF4M0nlM
CitedBy_id crossref_primary_10_1159_000506596
crossref_primary_10_1016_j_hlc_2023_10_020
crossref_primary_10_1097_MD_0000000000031587
crossref_primary_10_3390_jcm12155034
crossref_primary_10_14423_SMJ_0000000000001494
crossref_primary_10_4103_ejh_ejh_92_23
crossref_primary_10_1038_s41392_024_01916_y
crossref_primary_10_3389_fmed_2022_805415
crossref_primary_10_1183_13993003_00332_2020
crossref_primary_10_3892_etm_2024_12459
crossref_primary_10_1038_s41598_025_88887_4
crossref_primary_10_1161_HYPERTENSIONAHA_120_14525
crossref_primary_10_12677_jcpm_2024_32072
crossref_primary_10_1097_HJH_0000000000003807
crossref_primary_10_1038_s41598_024_53077_1
crossref_primary_10_1016_j_rdc_2019_04_005
crossref_primary_10_38109_2075_082X_2024_1_37_46
crossref_primary_10_12677_ACM_2023_1381862
crossref_primary_10_5812_mca_97040
crossref_primary_10_3390_medicina61010019
crossref_primary_10_1016_j_hrtlng_2024_08_018
crossref_primary_10_3892_mmr_2023_13133
Cites_doi 10.1161/CIRCULATIONAHA.114.006971
10.1378/chest.117.1.19
10.1056/NEJMra0800885
10.1016/j.vph.2016.08.009
10.1006/abbi.1993.1204
10.1056/NEJM196609012750902
10.1007/s00408-015-9694-x
10.1164/ajrccm/148.1.173
10.3310/hta7270
10.1053/rmed.2003.1440
10.1097/00029330-200812020-00006
10.1016/j.pharmthera.2016.12.004
10.1164/ajrccm.160.2.9812078
10.1016/j.rdc.2015.01.003
10.1016/j.crvi.2004.05.007
10.1016/0022-2828(89)90610-X
10.1016/j.transproceed.2014.10.070
10.7326/0003-4819-34-6-1421
10.1016/j.rmed.2012.09.003
10.1097/MD.0000000000002761
10.1136/annrheumdis-2013-203301
10.1253/circj.CJ-11-1237
10.1056/NEJM198501173120305
10.1203/PDR.0b013e318163a2e7
10.3892/etm.2015.2376
10.1536/ihj.48.523
10.1001/jama.300.8.924
10.17116/terarkh201587149-56
10.1080/15257770802138558
10.1016/j.semarthrit.2016.01.003
10.1016/j.mehy.2009.12.023
10.1073/pnas.78.11.6858
10.1097/RHU.0000000000000496
10.1007/s12288-011-0072-4
10.1016/j.healun.2014.01.853
10.1183/09031936.99.13368299
10.1378/chest.10-3331
10.1177/0961203315600539
10.1016/j.jclinepi.2009.06.005
10.1253/circj.CJ-11-1223
10.1097/00005344-200109000-00005
10.1007/s00296-010-1557-4
10.1111/1756-185X.12262
10.1136/heart.84.1.53
10.1093/eurheartj/ehp297
ContentType Journal Article
Copyright 2018 Japan College of Rheumatology 2018
Copyright_xml – notice: 2018 Japan College of Rheumatology 2018
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1080/14397595.2018.1537555
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1439-7609
EndPage 1041
ExternalDocumentID 30334638
10_1080_14397595_2018_1537555
1537555
Genre Article
Meta-Analysis
Systematic Review
Journal Article
GrantInformation_xml – fundername: Hanyang University
  grantid: HY-2014
GroupedDBID ---
.55
.86
00X
0R~
0VY
123
1N0
29M
2~H
36B
4.4
53G
5WD
6NX
8TC
AABZA
AACZT
AALUX
AAPXW
AARHZ
AAUAY
AAVAP
ABEIZ
ABEJV
ABJNI
ABNHQ
ABPQP
ABPTD
ABQNK
ABUPF
ABXVV
ACENM
ACGFS
ADCVX
ADINQ
ADIPN
ADQBN
ADRBQ
ADVEK
AECIN
AENEX
AFBBN
AFFZL
AGUTN
AGYJP
AHBYD
AHMBA
AHMMS
AIJEM
AJEEA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALQZU
ATGXG
BABNJ
BCRHZ
BEYMZ
BGNMA
BLEHA
BOHLJ
CCCUG
CS3
DKSSO
DU5
EBS
EMB
EMOBN
F5P
H13
HF~
HZ~
IHE
IZQ
KBUDW
KDC
KOP
KPH
KRBQP
KSI
KSN
KSSTO
KWAYT
KYCEM
LAS
LJTGL
M4Y
M4Z
NOMLY
NU-
NU0
O9-
OAM
OAUYM
OCZFY
OJZSN
OPAEJ
OVD
OWPYF
P2P
Q2X
R9I
RNS
ROX
RSV
S27
SDH
SMD
SOJ
SV3
T13
TDBHL
TEORI
TFDNU
TFL
TFW
TT1
V1S
WK8
X7M
AAYXX
ABDFA
ABGNP
ABVGC
ADNBA
ADVOB
AEMQT
AFXAL
AJNCP
ALXQX
CITATION
-Y2
2JY
2P1
2VQ
30V
408
409
40D
5VS
67Z
7X7
88E
8AO
8FI
8FJ
8G5
8UJ
95.
95~
AAIAL
AANXM
AARHV
AAYZH
ABMNI
ABTEG
ABUWG
ACKZS
ACOMO
ADBBV
ADFZZ
ADKPE
ADQRH
ADRFC
AFKRA
AFLOW
AGJBK
AHSBF
AMKLP
ASPBG
AVWKF
AZFZN
AZQEC
BA0
BENPR
BPHCQ
BVXVI
CAG
CCPQU
CGR
COF
CSCUP
CUY
CVF
CZDIS
DL5
DRXRE
DWQXO
DWTOO
ECM
EIF
EJD
EN4
FEDTE
FYUFA
GNUQQ
GUQSH
GXS
HG5
HG6
HMCUK
HMJXF
HVGLF
I09
IXC
IXE
IZIGR
I~X
M1P
M2O
MA-
NB0
NPM
O93
O9I
P9S
PADUT
PHGZT
PQQKQ
PROAC
PSQYO
QOS
RIG
ROL
RPX
S1Z
S37
S3B
TSK
TSV
TUC
U2A
UKHRP
VC2
WJK
Z45
~A9
7X8
ID FETCH-LOGICAL-c456t-2d6ddadf9460122309550faca5cb7e0aee9b155c03e4120ee6c1d2d92fd13d7f3
ISSN 1439-7595
1439-7609
IngestDate Sun Sep 28 09:06:40 EDT 2025
Thu Apr 03 07:06:18 EDT 2025
Wed Oct 01 02:16:03 EDT 2025
Thu Apr 24 22:57:57 EDT 2025
Wed Dec 25 09:07:45 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords hyperuricemia
prognosis
uric acid
Pulmonary hypertension
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c456t-2d6ddadf9460122309550faca5cb7e0aee9b155c03e4120ee6c1d2d92fd13d7f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ORCID 0000-0002-2084-7466
0000-0002-0208-0505
0000-0002-8521-6331
0000-0003-2018-2385
0000-0003-1467-2281
PMID 30334638
PQID 2122585094
PQPubID 23479
PageCount 11
ParticipantIDs crossref_citationtrail_10_1080_14397595_2018_1537555
crossref_primary_10_1080_14397595_2018_1537555
pubmed_primary_30334638
informaworld_taylorfrancis_310_1080_14397595_2018_1537555
proquest_miscellaneous_2122585094
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-11-02
PublicationDateYYYYMMDD 2019-11-02
PublicationDate_xml – month: 11
  year: 2019
  text: 2019-11-02
  day: 02
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Modern rheumatology
PublicationTitleAlternate Mod Rheumatol
PublicationYear 2019
Publisher Taylor & Francis
Publisher_xml – name: Taylor & Francis
References CIT0032
CIT0031
CIT0034
CIT0033
CIT0036
CIT0035
CIT0038
CIT0037
CIT0039
Zhang CY (CIT0022) 2013; 18
CIT0041
CIT0040
CIT0042
CIT0001
CIT0045
CIT0044
CIT0003
CIT0047
CIT0002
CIT0046
CIT0005
CIT0049
CIT0004
CIT0048
CIT0007
CIT0006
CIT0009
Li ZN (CIT0029) 2012; 92
CIT0008
CIT0050
Hasday JD (CIT0043) 1987; 135
CIT0051
CIT0010
Amariei DE (CIT0023) 2015; 191
CIT0012
CIT0011
Ozpelit E (CIT0030) 2017; 14
CIT0014
CIT0013
CIT0016
CIT0015
CIT0018
CIT0017
CIT0019
CIT0021
CIT0020
Jasiewicz M (CIT0027) 2015; 73
CIT0025
CIT0024
CIT0026
CIT0028
References_xml – ident: CIT0008
  doi: 10.1161/CIRCULATIONAHA.114.006971
– ident: CIT0014
  doi: 10.1378/chest.117.1.19
– ident: CIT0038
  doi: 10.1056/NEJMra0800885
– ident: CIT0026
  doi: 10.1016/j.vph.2016.08.009
– ident: CIT0039
  doi: 10.1006/abbi.1993.1204
– volume: 18
  start-page: e37
  year: 2013
  ident: CIT0022
  publication-title: Exp Clin Cardiol
– ident: CIT0037
  doi: 10.1056/NEJM196609012750902
– ident: CIT0017
  doi: 10.1007/s00408-015-9694-x
– ident: CIT0042
  doi: 10.1164/ajrccm/148.1.173
– ident: CIT0016
  doi: 10.3310/hta7270
– ident: CIT0003
  doi: 10.1053/rmed.2003.1440
– ident: CIT0019
  doi: 10.1097/00029330-200812020-00006
– ident: CIT0049
  doi: 10.1016/j.pharmthera.2016.12.004
– ident: CIT0013
  doi: 10.1164/ajrccm.160.2.9812078
– ident: CIT0009
  doi: 10.1016/j.rdc.2015.01.003
– ident: CIT0044
  doi: 10.1016/j.crvi.2004.05.007
– volume: 14
  start-page: 20
  year: 2017
  ident: CIT0030
  publication-title: J Geriatr Cardiol
– ident: CIT0040
  doi: 10.1016/0022-2828(89)90610-X
– volume: 191
  start-page: A4829
  year: 2015
  ident: CIT0023
  publication-title: Am Thoracic Soc
– volume: 92
  start-page: 3261
  year: 2012
  ident: CIT0029
  publication-title: Zhonghua Yi Xue Za Zhi
– ident: CIT0018
  doi: 10.1016/j.transproceed.2014.10.070
– ident: CIT0036
  doi: 10.7326/0003-4819-34-6-1421
– ident: CIT0002
  doi: 10.1016/j.rmed.2012.09.003
– ident: CIT0006
  doi: 10.1097/MD.0000000000002761
– ident: CIT0010
  doi: 10.1136/annrheumdis-2013-203301
– ident: CIT0034
  doi: 10.1253/circj.CJ-11-1237
– ident: CIT0041
  doi: 10.1056/NEJM198501173120305
– ident: CIT0012
  doi: 10.1203/PDR.0b013e318163a2e7
– ident: CIT0025
  doi: 10.3892/etm.2015.2376
– ident: CIT0020
  doi: 10.1536/ihj.48.523
– ident: CIT0050
  doi: 10.1001/jama.300.8.924
– ident: CIT0033
  doi: 10.17116/terarkh201587149-56
– ident: CIT0046
  doi: 10.1080/15257770802138558
– volume: 135
  start-page: 534
  issue: 3
  year: 1987
  ident: CIT0043
  publication-title: Am Rev Respir Dis
– ident: CIT0051
  doi: 10.1016/j.semarthrit.2016.01.003
– ident: CIT0045
  doi: 10.1016/j.mehy.2009.12.023
– ident: CIT0048
  doi: 10.1073/pnas.78.11.6858
– ident: CIT0035
  doi: 10.1097/RHU.0000000000000496
– ident: CIT0007
  doi: 10.1007/s12288-011-0072-4
– ident: CIT0024
  doi: 10.1016/j.healun.2014.01.853
– volume: 73
  start-page: 286
  year: 2015
  ident: CIT0027
  publication-title: Cytokine
– ident: CIT0011
  doi: 10.1183/09031936.99.13368299
– ident: CIT0031
  doi: 10.1378/chest.10-3331
– ident: CIT0004
  doi: 10.1177/0961203315600539
– ident: CIT0015
  doi: 10.1016/j.jclinepi.2009.06.005
– ident: CIT0032
  doi: 10.1253/circj.CJ-11-1223
– ident: CIT0047
  doi: 10.1097/00005344-200109000-00005
– ident: CIT0005
  doi: 10.1007/s00296-010-1557-4
– ident: CIT0028
  doi: 10.1111/1756-185X.12262
– ident: CIT0021
  doi: 10.1136/heart.84.1.53
– ident: CIT0001
  doi: 10.1093/eurheartj/ehp297
SSID ssj0035989
Score 2.320212
SecondaryResourceType review_article
Snippet Objectives: To investigate the association of hyperuricemia with pulmonary hypertension (PH) in term of subsequent development, severity, and prognosis of PH....
To investigate the association of hyperuricemia with pulmonary hypertension (PH) in term of subsequent development, severity, and prognosis of PH. The authors...
Objectives: To investigate the association of hyperuricemia with pulmonary hypertension (PH) in term of subsequent development, severity, and prognosis of...
SourceID proquest
pubmed
crossref
informaworld
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1031
SubjectTerms Female
Humans
Hypertension, Pulmonary - blood
Hypertension, Pulmonary - complications
Hypertension, Pulmonary - epidemiology
hyperuricemia
Hyperuricemia - blood
Hyperuricemia - complications
Hyperuricemia - epidemiology
Male
Middle Aged
Odds Ratio
Prognosis
Pulmonary hypertension
uric acid
Uric Acid - blood
Title Association of hyperuricemia and pulmonary hypertension: A systematic review and meta-analysis
URI https://www.tandfonline.com/doi/abs/10.1080/14397595.2018.1537555
https://www.ncbi.nlm.nih.gov/pubmed/30334638
https://www.proquest.com/docview/2122585094
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVLSH
  databaseName: SpringerLink Journals
  customDbUrl:
  mediaType: online
  eissn: 1439-7609
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0035989
  issn: 1439-7595
  databaseCode: AFBBN
  dateStart: 19970301
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9NAFB6FVEJcEDtl0yBxixy8jj3cXEQVtWqFRCKVC9azPVartk4V7EP7R_p3ebPYGdNAKRcrmmSex35f5i3zFkI-MIAiqCpwCmCVE0pzB4BFThglQpabS0omc4cPDtlsEe4dRUej0bUVtdQ2-bS42phX8j9cxTHkq8ySvQNne6I4gJ-Rv3hFDuP1n3hsvVul9KFNuVJVgs51qtXkoj3DxcjAOPWdilbXsRzpjRrOOjT4XDTggKlUYmuupmna6li0OGngjF-cTvaN23kOPVC-mijs_ct28n1pBCT0_Ztnl2092WvX4-lxrceFbH_07eTUdkh4XGXmWT5K1MC4E0e6d-ZUWGPM5fbGa1wdJzd2Udl6wpLIaDF6G3d7HR4pacvbyTi9ZIo7eBxF0Vq8dUf6v0m9PhbRM0VSOzKZJJMZMvfIlh8z5o_JVrq7s3PYCXlZ95CrxDXzrF1yWOJ-3LiegdozKIr7Z9NGqTjzR-ShsU1oqoH2mIxE_YTcPzDRF0_JDwtvdFnRAd4ooof2eKM23j7RlK7RRjXa1O8HaHtGFrtf5p9njunP4RSodjeOX7KyhLLiIZMHtIGsZuhWUEBU5LFwQQieo7pauIEIPd8VghVe6Zfcr0ovKOMqeE7G9bIWLwnNc_BVmjb4RZjHPvAEeFUGKBQgERBuk7B7fVlhitfLHipn2V_Zt02m_bQLXb3ltgnc5k3WKLdZpXvcZMEtc993jMxwj5YHb1CLZfszQ_XQR7Pc5fgcLzSH--WgChmEKARf3XWpr8mD9b_vDRk3q1a8RQW5yd8ZsP4CR7Oy9Q
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+hyperuricemia+and+pulmonary+hypertension%3A+A+systematic+review+and+meta-analysis&rft.jtitle=Modern+rheumatology&rft.au=Uk+Kang%2C+Tae&rft.au=Park%2C+Kyu+Yong&rft.au=Kim%2C+Hyun+Jung&rft.au=Ahn%2C+Hyeong+Sik&rft.date=2019-11-02&rft.issn=1439-7595&rft.eissn=1439-7609&rft.volume=29&rft.issue=6&rft.spage=1031&rft.epage=1041&rft_id=info:doi/10.1080%2F14397595.2018.1537555&rft.externalDBID=n%2Fa&rft.externalDocID=10_1080_14397595_2018_1537555
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1439-7595&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1439-7595&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1439-7595&client=summon